How to read an endotoxin report: units, limits and test interference
Read an endotoxin result together with its units, reporting limit, sample description and validity checks. A low number without that context is incomplete evidence. A test-suitability “Pass” may mean the controls worked, while a product-specification pass answers a separate question. Neither establishes sterility or suitability for administration.
Identify the endpoint before reading the number
Bacterial endotoxin testing targets endotoxins associated with Gram-negative bacteria. Reports may name Limulus amebocyte lysate, or LAL, or recombinant reagents such as recombinant Factor C and recombinant cascade reagent. Record the actual method; “microbial testing” is too broad a description.
Endotoxins are one category of pyrogen. A bacterial endotoxin result cannot exclude all other fever-producing contaminants. Likewise, chemical purity and sterility are separate endpoints. The comparison below is a guide to the question each measurement answers, not a ranking of laboratories.
| Reported test | What it addresses | What it cannot establish alone |
|---|---|---|
| HPLC purity | Relative chromatographic signal under the stated method. | Sterility or endotoxin status. |
| Bacterial endotoxins | Endotoxin detected or bounded by a stated method and limit. | All pyrogens or absence of viable microorganisms. |
| Sterility test | Microbial growth under defined test conditions. | Endotoxin status or certainty about every unit. |
EU/mL and EU/mg need a documented reporting basis
EU means endotoxin units. EU/mL expresses a result per millilitre of a specified solution; EU/mg expresses it per milligram of a specified material. Those denominators are different. Comparing the printed numbers without their basis can reverse the apparent meaning of two reports.
Ask whether the laboratory reported the tested solution, corrected back to the original sample, or normalised to material mass. For a mass-based result, establish what “mg” represents: gross powder, a specified salt or peptide content. These are not automatically equivalent.
A useful comparison therefore requires the laboratory’s documented concentration and correction basis. Do not supply missing preparation information from the vial label or apply a second dilution correction to an already corrected result. Ask for clarification rather than constructing a conversion from assumptions.
Keep the less-than sign and its limit
A less-than result is a bound under the stated method, not a measurement of zero. “Not detected” also needs a defined reporting or detection limit. Preserve the qualifier, units and limit when copying the result into a comparison sheet.
The effective detection limit for the original sample depends on assay sensitivity and the dilution used. A reagent’s advertised sensitivity need not equal the final reporting limit for the original material. Ask the laboratory which limit applies to the reported result and whether it supports comparison with the stated specification.
Check what “Pass” actually labels
Sample components can inhibit or enhance the assay response. A positive product control, often described through spike recovery, checks whether a known endotoxin addition is recovered appropriately in that sample matrix. An invalid control cannot be treated as reassurance about a low sample result.
Charles River’s nexgen-PTS guide provides a useful example: its test-suitability Pass/Fail evaluates assay validity. That field is separate from the endotoxin value. On any report, identify whether “Pass” labels suitability, a numerical specification or a broader laboratory conclusion.
Request the method-suitability conclusion and any interference qualification. A brief COA may omit supporting control data; that is a reason to ask for the supporting report, rather than to assume either success or failure.
Separate sample evidence from a batch-wide conclusion
Record whether testing covered bulk material, one finished container or a composite of several containers. Pooling can dilute a more contaminated unit among others. FDA also notes that sample handling can change detectable endotoxin, so the submitted material and its history matter.
A sterility test has its own sampling limitation: a small set of tested units may miss contamination elsewhere in the batch. A negative result supports a defined sample-based conclusion; it does not establish that every supplied unit was tested.
Acceptance criteria require context. A threshold copied from another product or report is not a universal “safe” level for research material. Record the specification and its stated basis separately from the measured result. These references do not turn an analytical report into approval for human or veterinary administration.
A short checklist for the report file
1. Keep the original report, issuing laboratory, report ID, date and exact sample identifier together.
2. Copy the method, result, units and any less-than qualifier exactly. Identify the reporting basis.
3. Check the applicable limit and the test-validity conclusion. Ask what any “Pass” field means.
4. Record the sampling scope and any unresolved connection between the tested sample and supplied material.
5. Keep chemical purity, endotoxin and sterility findings on separate lines. Mark missing evidence as missing.
Use FSD’s report library to review the documents actually available, then use the traceability guide for the sample-to-material connection. This article contains no new FSD test results and makes no claim that a published report covers current stock.
Common questions
Can I compare EU/mL with EU/mg directly?
No. Ask for a common reporting basis supported by the laboratory’s sample concentration and corrections. Matching product names or labelled amounts do not provide that missing information.
Does a suitability pass mean the sample meets its specification?
Not necessarily. Suitability can describe whether the test controls passed. Read the separate sample result and the specification to which it was compared.
Does high HPLC purity remove the need to ask about endotoxins?
No. Chromatographic purity describes a chemical measurement. An endotoxin conclusion requires the relevant separate test; neither result supplies a sterility conclusion.
Sources & scope
These references explain analytical and research principles. They do not certify FSD BIO LABS or provide evidence about a particular FSD batch.
- Pyrogen and Endotoxins Testing: Questions and Answers, Edition 2 (March 2026) — FDA
Questions 1, 3, 4, 6, 7 and 9 address sampling, handling, pooling, method comparison, context-specific limits and non-endotoxin pyrogens. Used for analytical principles, not to apply pharmaceutical acceptance limits or claim regulatory approval for research materials. - USP General Chapter <86>: Bacterial Endotoxins Test Using Recombinant Reagents — United States Pharmacopeia
Public chapter preview identifies recombinant Factor C and recombinant cascade reagents as methods for detecting or quantifying Gram-negative bacterial endotoxins. No claim about FSD testing methods or current compendial compliance is inferred. - Endosafe nexgen-PTS Product Sheet: Interpretation of Results — Charles River Laboratories
Page 2 distinguishes test-suitability Pass/Fail from the reported sample value and describes spike recovery, dilution/concentration input and sensitivity-adjusted reporting. The example is a manufacturer reporting convention, not evidence that an FSD sample used this instrument. - Endotoxin Testing Sensitivity: How to Choose the Right BET Assay Sensitivity — Charles River Laboratories
Explains the relationship between sensitivity, sample dilution, matrix interference, spike recovery and maximum valid dilution. Its example application limits, numerical ranges and product comparisons are not adopted here. - Sterile Drug Products Produced by Aseptic Processing: Current Good Manufacturing Practice — FDA
Section XI explains method controls and the limited ability of small sterility-test samples to detect contamination throughout a batch. Used to explain sampling and endpoint limits, not to suggest FSD follows sterile-drug manufacturing requirements. - Quality Control of Amino Acids & Peptides: A Guide — Bachem
Distinguishes HPLC peak-area purity from peptide content and separate microbiological analysis. Supports keeping chemical composition, the mass reporting basis and microbial endpoints separate.